These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9764984)

  • 1. In vitro inhibition of the hepatitis delta virus replication mediated by interferon and trans-ribozyme or antisense probes.
    Madejón A; Bartolomé J; Carreño V
    J Hepatol; 1998 Sep; 29(3):385-93. PubMed ID: 9764984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of hepatitis delta virus replication to interferon-alpha treatment in transfected human cells.
    Ilan Y; Klein A; Taylor J; Tur-Kaspa R
    J Infect Dis; 1992 Nov; 166(5):1164-6. PubMed ID: 1328404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antiviral effect in cell culture of type 1 interferon and ribozymes targeting HCV RNA.
    Macejak DG; Jensen KL; Pavco PA; Phipps KM; Heinz BA; Colacino JM; Blatt LM
    J Viral Hepat; 2001 Nov; 8(6):400-5. PubMed ID: 11703570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis delta virus replication in vitro is not affected by interferon-alpha or -gamma despite intact cellular responses to interferon and dsRNA.
    McNair AN; Cheng D; Monjardino J; Thomas HC; Kerr IM
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1371-8. PubMed ID: 7911507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of mouse hepatitis virus multiplication by antisense oligonucleotide, antisense RNA, sense RNA and ribozyme.
    Mizutani T; Hayashi M; Maeda A; Sasaki N; Yamashita T; Kasai N; Namioka S
    Adv Exp Med Biol; 1993; 342():129-35. PubMed ID: 8209719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of viral replication by ribozyme: mutational analysis of the site and mechanism of antiviral activity.
    Zhang Z; Burke JM
    J Virol; 2005 Mar; 79(6):3728-36. PubMed ID: 15731266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extension of helix II of an HIV-1-directed hammerhead ribozyme with long antisense flanks does not alter kinetic parameters in vitro but causes loss of the inhibitory potential in living cells.
    Homann M; Tabler M; Tzortzakaki S; Sczakiel G
    Nucleic Acids Res; 1994 Sep; 22(19):3951-7. PubMed ID: 7524030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of viral multiplication in cells chronically infected with mouse hepatitis virus by antisense RNA against the polymerase gene.
    Maeda A; Hayashi M; Mizutani T; Ishida K; Watanabe T; Namioka S
    J Vet Med Sci; 1995 Jun; 57(3):563-5. PubMed ID: 7548422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A circular trans-acting hepatitis delta virus ribozyme.
    Puttaraju M; Perrotta AT; Been MD
    Nucleic Acids Res; 1993 Sep; 21(18):4253-8. PubMed ID: 7692400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular inhibition of the replication of hepatitis B virus by hammerhead ribozymes.
    Feng Y; Kong YY; Wang Y; Qi GR
    J Gastroenterol Hepatol; 2001 Oct; 16(10):1125-30. PubMed ID: 11686839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation on activities of hammerhead ribozyme embedded in genomic RNA of hepatitis delta virus].
    Li XJ; Kuang ES; Dai W; Yang FH; Wang M; Wang HS; Zhou BP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):12-5. PubMed ID: 16201462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of viral multiplication in acute and chronic stages of infection by ribozymes targeted against the polymerase gene of mouse hepatitis virus.
    Maeda A; Mizutani T; Hayashi M; Ishida K; Watanabe T; Namioka S
    Adv Exp Med Biol; 1995; 380():399-404. PubMed ID: 8830515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient inhibition of hepatitis B virus replication by hammerhead ribozymes delivered by hepatitis delta virus.
    Li X; Kuang E; Dai W; Zhou B; Yang F
    Virus Res; 2005 Dec; 114(1-2):126-32. PubMed ID: 16054262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design.
    Tabler M; Homann M; Tzortzakaki S; Sczakiel G
    Nucleic Acids Res; 1994 Sep; 22(19):3958-65. PubMed ID: 7937118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reaction pathway of the trans-acting hepatitis delta virus ribozyme: a conformational change accompanies catalysis.
    Pereira MJ; Harris DA; Rueda D; Walter NG
    Biochemistry; 2002 Jan; 41(3):730-40. PubMed ID: 11790094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mimicry of the hepatitis delta virus replication cycle mediated by synthetic circular oligodeoxynucleotides.
    Diegelman AM; Kool ET
    Chem Biol; 1999 Aug; 6(8):569-76. PubMed ID: 10421762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of the in vitro antiviral activity of an engineered M1GS ribozyme that targets to the core gene of hepatitis C virus].
    Zhang W; Li X; Luo G; Huang Z; Liu Y
    Wei Sheng Wu Xue Bao; 2013 Aug; 53(8):875-81. PubMed ID: 24341280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constructing an efficient trans-acting genomic HDV ribozyme.
    Kawakami J; Yuda K; Suh YA; Kumar PK; Nishikawa F; Maeda H; Taira K; Ohtsuka E; Nishikawa S
    FEBS Lett; 1996 Sep; 394(2):132-6. PubMed ID: 8843150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribozyme-independent replication of a defective hepatitis D virus RNA derived from hepatitis B/D patients receiving antiviral therapy.
    Hsu CW; Yeh CT
    Biochem Biophys Res Commun; 2014 Jul; 450(1):616-21. PubMed ID: 24931669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significantly improved rescue of rabies virus from cDNA plasmids.
    Ghanem A; Kern A; Conzelmann KK
    Eur J Cell Biol; 2012 Jan; 91(1):10-6. PubMed ID: 21397981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.